Males. You must agree to the following during the study and for at least 90 days after the last dose of study drug: • Refrain from donating sperm • Be abstinent from heterosexual intercourse as your preferred and usual lifestyle (abstinent on a long-term and persistent basis) and agree to remain abstinent Must agree to use birth control/barrier as detailed below: • Agree to use a male condom and should also be advised of the benefit for a female partner to use a highly effective method of birth control as a condom may break or leak when having sexual intercourse with a female able to have children who is not currently pregnant • In addition to male condom use, a highly effective method of birth control may be considered in female partners able to have children of male participants • Implantable progestogen-only hormone birth control • Intrauterine device (IUD) • Intrauterine hormone-releasing system (IUS) • Bilateral tubal occlusion (both tubes blocked) which includes bilateral tubal ligation (both tubes tied) • Partner has a vasectomy (absence of sperm confirmed) • Hormonal birth control*(See Note Below) • Sexual abstinence – defined as refraining from heterosexual intercourse and is the preferred and usual lifestyle of the participant *Note: One of the following barrier methods must be used in addition to the hormonal birth control methods: • Male or female condom with or without spermicide • Cervical cap, diaphragm, or sponge with spermicide • A combination of male condom with either cervical cap, diaphragm, or sponge with spermicide (double-barrier methods) The effects of the study drug on the following are not known and may involve unforeseeable risks: • Fertility • Sperm • Pregnancy • Unborn child • Breastfeeding child Even if you use birth control during the study, there is a chance your partner could become pregnant. If your partner is pregnant or becomes pregnant during the study, the study drug or procedure may involve unforeseeable risks to the unborn child. A pregnancy test is not always right, especially in the early stages of pregnancy. You cannot participate in this study if: • You are a man whose female partner is currently pregnant or planning to become pregnant If you want to stop your required birth control during the study, you should tell the study investigator
Males a) Hair, when combed, brushed, picked, blown, teased, or otherwise worn, will not exceed two inches (2") in height.
b) Hair, when combed, or otherwise worn, will not extend below the midpoint of the uniform shirt collar of a properly worn uniform shirt.
c) Hair, when combed, brushed, or otherwise worn will not fall farther than the middle of the ear.
Males. You must agree to the following during the study and for at least 90 days after the last dose of study drug: • Refrain from donating sperm • Be abstinent from heterosexual or homosexual intercourse as your preferred and usual lifestyle (abstinent on a long-term and persistent basis) and agree to remain abstinent Must agree to use birth control/barrier as detailed below: • Agree to use a male condom when engaging in any activity that allows for the passage of ejaculate to another person • Male participants should be advised of the benefit for a female partner to use a highly effective method of birth control as a condom may break or leak when having sexual intercourse with a female able to have children who is not currently pregnant. They must inform their female partner(s) of the risk and strongly recommend she uses a highly effective method of birth control Low user dependency methods (methods that do not rely on you to remember to use them) • Implantable hormone birth control • Intrauterine device (IUD) • Intrauterine hormone-releasing system (IUS) • Bilateral tubal occlusion (both tubes blocked) which includes bilateral tubal ligation (both tubes tied) • Vasectomy (absence of sperm confirmed) User dependent methods (methods that rely on you to remember to use them) • Hormonal birth control • Sexual abstinence – defined as refraining from heterosexual intercourse and is the preferred and usual lifestyle of the participant The study doctor or study staff will discuss these contraceptive methods with you.
Males. Chronic opioid use has been associated with low testosterone levels in males. This may affect mood, stamina, sexual desire, and physical and sexual performance. Therefore, my doctor may test my blood testosterone levels.
Males. A 1:1 mating scheme is employed. Males may be live-spawned on the first spawning day as necessary to make up for a low naturally-occurring male to female ratio. However, inclusion of xxxx xxxxxxx in the run-at-large broodstock collections helps to alleviate occasional low adult male occurrence.
Males. The effects of rezafungin on reproduction (i.e. abnormalities in offspring or a decrease in the ability to get a partner pregnant) have shown potential risks in men (sperm abnormalities). Even if you use birth control during the study, there is a chance your partner could become pregnant. If your partner becomes pregnant during the study, the study drug may involve unforeseeable risks to the unborn baby. Therefore, if you have not had a vasectomy, you must agree to use condoms with spermicide for birth control from the first day of the study until at least 18 weeks (126 days) after your last dose of rezafungin. You must also not donate sperm from the first day of the study until at least 18 weeks (126 days) after the last dose of rezafungin. If at any time during the study, your female partner becomes pregnant, you must immediately contact the study doctor.
Males. 1 Shirt and 1 pair Pants or 1 pair Shorts and 1 Shirt; OR
Males. You must agree to the following during the study and for at least 28 days after the last dose of study drug. Refrain from donating sperm Be abstinent from heterosexual intercourse with a female able to have children as your preferred and usual lifestyle (abstinent on a long-term and persistent basis) and agree to remain abstinent Must agree to use birth control as detailed below: Agree to use a male condom when engaging in any activity that allows for passage of ejaculate to another person. In addition to male condom use, female partners able to have children may consider an additional highly effective birth control method such as the methods detailed earlier in this document and the following: U ser dependent methods (methods that rely on you to remember to use them) Combined (estrogen and progestogen containing) hormonal birth control o Oral o Intravaginal o Transdermal Progestogen containing hormonal birth control o Oral o Injectable Be abstinent from heterosexual intercourse as your preferred and usual lifestyle (abstinent on a long-term and persistent basis) and agree to remain abstinent during the entire risk period N ote: For female partners able to have children, one of the following barrier methods must be used in a ddition to the user dependent birth control methods detailed above: Male or female condom with or without spermicide Cervical cap, diaphragm, or sponge with spermicide A combination of male condom with either cervical cap, diaphragm, or sponge with spermicide (double-barrier methods) The effects of the study drug on the following are not known and may involve unforeseeable risks: Sperm Pregnancy Unborn child Breastfeeding child The effects of the study drug on reproduction are unknown. At this time, it is not known whether the study drug can cause harm to the fetus or whether it is secreted in human milk. Therefore, the study drug should not be administered to pregnant women or women who are breastfeeding. An appropriate method of contraception is required. Even if you use birth control during the study, there is a chance you or your partner, could become pregnant. If you or your partner are pregnant or become pregnant, during the study, the study drug or procedure may involve unforeseeable risks to the unborn child. A pregnancy test is not always right, especially in the early stages of pregnancy. If you are currently pregnant, plan to become pregnant, or are breastfeeding a child, you cannot join this study....
Males. We do not insist on neutering. If you don't believe the findings of the new studies then we recommend a vasectomy vice castration. If you insist on neutering wait until the dog is 18 months old.
Males a) On return from parental leave, the Employee will be employed in the position he held immediately before that period.
b) If that position no longer exists but he is qualified for, and can perform the duties of, other positions in the Company, he will be employed in whichever of those positions is nearest in status and remuneration to the position he held prior to taking leave.
